Nettet24. jan. 2024 · Insys hatte im Juni um Gläubigerschutz nachgesucht und in diesem Rahmen die Rechte am Fentanyl-Spray verkauft. Vor einigen Tagen gab ein Gericht seine Zustimmung zur Abwicklung des Unternehmens. In December 2016, seven former executives and managers employed by Insys were taken into custody, including CEO John Kapoor and charged with conspiracy to bribe medical staff in several states to prescribe a specific pain medication to their patients. The accusations were the topic of an NBC special feature report on Megyn Kelly's Sunday Night on June 4, 2024. In August 2024, Insys Therapeutics was sued by Arizona Attorney General Mark Brnovich for mis…
Opioid Company
Nettet9. des. 2024 · Founded in 1990 and incorporated in 2002, Insys Therapeutics tapped an opioid market niche by selling TIRF (transmucosal immediate-release fentanyl) medications, which are intended for "breakthrough" pain in cancer patients already taking other opioid painkillers. Subsys, the company's patented spray-delivery TIRF, was … Nettet5. jun. 2024 · Insys, the Opioid Drug Maker, to Pay $225 Million to Settle Fraud Charges Federal prosecutors accused the company of illegally marketing its powerful fentanyl … lambeth active
Watch: Carrollton mother speaks on fentanyl’s devastating impact …
Nettet28. jan. 2024 · Insys Therapeutics said in August said it would pay $150 million to resolve a Department of Justice investigation related to its marketing of the fentanyl spray Subsys. Nettet5. jun. 2024 · Insys’s drug Subsys is a sublingual fentanyl spray, a powerful, but highly addictive, opioid painkiller. In 2012, Subsys was approved by the Food and Drug … Nettet26. nov. 2024 · As part of her practice, Alfonso prescribed various controlled substances, including Subsys, a fentanyl-based sublingual spray that was approved by the Food … heloise rabache winkey